EU Health Technology Assessment Brief

Headline

European Commission publishes two delegated acts expanding the well-established technologies list under the Medical Devices Regulation

Executive Summary

The European Commission's Health and Food Safety Directorate-General published two delegated acts on June 29, 2026, expanding the list of well-established technology devices under the Medical Devices Regulation. The acts enter into force 20 days after publication in the Official Journal of the EU.

Bottom Line

Two delegated acts published June 29, 2026, expand the well-established technologies device list under the Medical Devices Regulation, bringing proportionality relief on certain requirements for manufacturers of listed devices. The acts enter into force 20 days after Official Journal publication. Cresthaven reading: manufacturers of devices in the well-established technologies categories covered by the expanded list sit inside a modified compliance pathway once the acts take effect, while manufacturers outside the list remain subject to the standard Medical Devices Regulation requirements.

Key Regulatory Signals

• Proportionality Relief for Listed Device Manufacturers: The two delegated acts expand the well-established technologies list under the Medical Devices Regulation, making certain regulatory requirements more proportionate for manufacturers of devices included on that list. Cresthaven reading: manufacturers whose devices appear on the expanded list face a reduced compliance burden relative to the standard Medical Devices Regulation pathway, though the source does not enumerate which specific requirements are modified.
• Entry Into Force Within 20 Days: The delegated acts entered the Official Journal of the EU on June 29, 2026, and are stated to enter into force 20 days from that date. This places the effective date at approximately July 19, 2026, though the source does not state that date explicitly.
• List Developed Through a Structured Expert Process: The well-established technologies device list was developed in 2025 by a dedicated Task Force of national experts from the Medical Device Coordination Group, following a call for evidence that incorporated stakeholder input. The list reflects devices with common and stable designs, well-known safety and clinical performance characteristics, and a long market history.
• Commission Simplification Agenda Alignment: The Commission frames the delegated acts as in line with its simplification agenda, making certain requirements more proportionate for devices on the list to reduce the burden on manufacturers.

Regulatory Delta

• No direct precedent exists for delegated acts expanding a well-established technologies list under the Medical Devices Regulation.
• The expansion moves the WET list from a 2025 expert-development phase into binding law, converting Task Force output into enforceable proportionality relief for listed manufacturers.
• The action aligns with the Commission's stated simplification agenda and the Medical Device Coordination Group's coordination function across member states, signaling continued use of the WET mechanism as a tool for reducing regulatory burden.

Materiality Classification

MEDIUM — Delegated acts with a 20-day entry-into-force window that make certain requirements more proportionate for manufacturers of devices on the expanded well-established technologies list.

Intelligence Outlook

Monitor the Official Journal of the EU and the Medical Device Coordination Group for the full enumeration of devices added to the well-established technologies list and any subsequent implementing measures under this rulemaking.